Debbie Marriott

2.4k total citations
38 papers, 1.3k citations indexed

About

Debbie Marriott is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Debbie Marriott has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Infectious Diseases and 8 papers in Pharmacology. Recurrent topics in Debbie Marriott's work include Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and HIV/AIDS drug development and treatment (5 papers). Debbie Marriott is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and HIV/AIDS drug development and treatment (5 papers). Debbie Marriott collaborates with scholars based in Australia, United States and China. Debbie Marriott's co-authors include Indy Sandaradura, Sahand Imani, Sheridan Gentili, Hergen Buscher, Sebastiaan J. van Hal, Janaki Amin, D. Stark, John Ellis, Andrew Carr and John E. Ray and has published in prestigious journals such as Immunity, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Debbie Marriott

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debbie Marriott Australia	18	572	494	404	170	160	38	1.3k
John Zurlo United States	14	322 0.6×	641 1.3×	356 0.9×	186 1.1×	95 0.6×	38	1.4k
P. A. Pizzo United States	24	605 1.1×	758 1.5×	171 0.4×	184 1.1×	150 0.9×	35	2.3k
Michael Sands United States	20	239 0.4×	530 1.1×	113 0.3×	176 1.0×	76 0.5×	44	1.2k
Michel Duong France	20	830 1.5×	560 1.1×	136 0.3×	88 0.5×	352 2.2×	53	1.4k
Helen Sambatakou Greece	15	940 1.6×	745 1.5×	105 0.3×	40 0.2×	143 0.9×	47	1.3k
Yu‐Chung Chuang Taiwan	27	909 1.6×	1.0k 2.1×	294 0.7×	154 0.9×	119 0.7×	122	2.3k
I. M. Hoepelman Netherlands	24	307 0.5×	698 1.4×	219 0.5×	76 0.4×	36 0.2×	66	1.4k
R. Garraffo France	19	555 1.0×	313 0.6×	340 0.8×	120 0.7×	359 2.2×	92	1.3k
Dante Bassetti Italy	20	647 1.1×	379 0.8×	132 0.3×	157 0.9×	249 1.6×	72	1.3k
Daniel B. Chastain United States	18	474 0.8×	493 1.0×	80 0.2×	80 0.5×	132 0.8×	109	1.1k

Countries citing papers authored by Debbie Marriott

Since Specialization

Citations

This map shows the geographic impact of Debbie Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie Marriott more than expected).

Fields of papers citing papers by Debbie Marriott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie Marriott. The network helps show where Debbie Marriott may publish in the future.

Co-authorship network of co-authors of Debbie Marriott

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie Marriott. A scholar is included among the top collaborators of Debbie Marriott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie Marriott. Debbie Marriott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Neoh, Chin Fen, Sharon C.‐A. Chen, Amy Crowe, et al.. (2023). InvasiveScedosporiumandLomentospora prolificansInfections in Australia: A Multicenter Retrospective Cohort Study. Open Forum Infectious Diseases. 10(2). ofad059–ofad059. 18 indexed citations

2.

Neoh, Chin Fen, Sharon C.‐A. Chen, David C. M. Kong, et al.. (2023). Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study. Journal of Antimicrobial Chemotherapy. 79(1). 46–54. 2 indexed citations

3.

Katelaris, Anthea L, Trang Thi Huyen Nguyen, Qinning Wang, et al.. (2023). Toxigenic cutaneous diphtheria without recent travel, Sydney, Australia, 2022. The Medical Journal of Australia. 220(3). 126–128. 1 indexed citations

4.

Hou, Jingjing, Debbie Marriott, Dario Cattaneo, et al.. (2022). Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey. Frontiers in Pharmacology. 13. 992354–992354. 6 indexed citations

5.

Alffenaar, Jan‐Willem C., Anne‐Grete Märtson, Scott K. Heysell, et al.. (2021). Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections. Clinical Pharmacokinetics. 60(6). 711–725. 29 indexed citations

6.

Sandaradura, Indy, Emma Goeman, Ellen Fine, et al.. (2020). A close shave? Performance of P2/N95 respirators in healthcare workers with facial hair: results of the BEARDS (BEnchmarking Adequate Respiratory DefenceS) study. Journal of Hospital Infection. 104(4). 529–533. 45 indexed citations

7.

Gould, Michael K., Andrew N. Ginn, Debbie Marriott, Ross Norris, & Indy Sandaradura. (2019). Urinary piperacillin/tazobactam pharmacokinetics in vitro to determine the pharmacodynamic breakpoint for resistant Enterobacteriaceae. International Journal of Antimicrobial Agents. 54(2). 240–244. 9 indexed citations

8.

Imani, Sahand, Hergen Buscher, Richard O. Day, et al.. (2018). An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy. European Journal of Clinical Microbiology & Infectious Diseases. 37(11). 2171–2175. 23 indexed citations

9.

Biswas, Chayanika, S.C.-A. Chen, Catriona Halliday, et al.. (2017). Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study. Clinical Microbiology and Infection. 23(9). 676.e7–676.e10. 33 indexed citations

10.

Imani, Sahand, Hergen Buscher, Debbie Marriott, Sheridan Gentili, & Indy Sandaradura. (2017). Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships. Journal of Antimicrobial Chemotherapy. 72(10). 2891–2897. 204 indexed citations

11.

Amin, Janaki, et al.. (2012). Skeletal Muscle Toxicity Associated With Raltegravir-Based Combination Antiretroviral Therapy in HIV-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(5). 525–533. 31 indexed citations

12.

McMullan, Brendan, Catriona Halliday, Tania C. Sorrell, et al.. (2012). Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory. PLoS ONE. 7(11). e49541–e49541. 86 indexed citations

13.

Seddiki, Nabila, Sarah C. Sasson, Brigitte Santner‐Nanan, et al.. (2009). Proliferation of weakly suppressive regulatory CD4⁺ T cells is associated with over‐active CD4⁺ T‐cell responses in HIV‐positive patients with mycobacterial immune restoration disease. European Journal of Immunology. 39(2). 391–403. 99 indexed citations

14.

Hamilton, A. R., Anthony D. Kelleher, & Debbie Marriott. (2009). A case of severe visceral leishmaniasis resulting from travel to Greece: Table 1. BMJ Case Reports. 2009. bcr0620092036–bcr0620092036. 2 indexed citations

15.

Kostenko, Lyudmila, Anthony W. Purcell, Nicholas A. Williamson, et al.. (2008). Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity. Immunity. 29(1). 165–165. 1 indexed citations

16.

Kostenko, Lyudmila, Anthony W. Purcell, Nicholas A. Williamson, et al.. (2008). Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity. Immunity. 28(6). 822–832. 248 indexed citations

17.

Marriott, Debbie, et al.. (2006). Secondary syphilis presenting as tonsillitis in three patients. The Journal of Laryngology & Otology. 120(7). 602–604. 17 indexed citations

18.

Ray, John E., Debbie Marriott, Mark Bloch, & Andrew J. McLachlan. (2005). Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic. British Journal of Clinical Pharmacology. 60(3). 291–299. 46 indexed citations

19.

Winston, Alan, Mark Bloch, Andrew Carr, et al.. (2005). Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 56(2). 380–387. 42 indexed citations

20.

Dore, Gregory J., Debbie Marriott, & Johan Duflou. (1995). Clinico‐pathological study of cytomegalovirus (CMV) in AIDS autopsies: under‐recognition of CMV pneumonitis and CMV adrenalitis. Australian and New Zealand Journal of Medicine. 25(5). 503–506. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact